
Scan other fragrance and beauty suppliers leaning into greener chemistry with the hand picked list of solid balance sheet and fundamentals (25 results), which could complement a thesis around International Flavors & Fragrances' AQUASCENT shift.
To own International Flavors & Fragrances, you need to believe the refocused Taste, Scent and Health & Biosciences portfolio can support better earnings over time, even as revenue is forecast to decline 5.7% a year. AQUASCENT fits that story but does not change the near term reliance on execution, cost removal and cash generation.
The short term swing factor remains whether margin work and asset sales translate into the profit recovery analysts expect from a current loss of US$791.0 million. The biggest risk stays the same. Softer demand in North America, China and Health & Biosciences could keep growth weak and make those margin targets harder to reach.
AQUASCENT is the announcement that matters most here because it sits in Scent, one of the higher margin areas that the Food Ingredients sale is meant to spotlight. Management is trying to make that smaller, focused portfolio justify higher R&D intensity of roughly 9% of sales with tangible platforms customers actually adopt.
If brands lean into AQUASCENT for higher fragrance loads and lower shipping weight, it could help validate that R&D spend and support the catalyst of better pricing power in Scent. If uptake is limited, it would add to the existing risk that new platforms like ENVIROCAP and SENSORA do not deliver enough product wins to offset weak end markets.
International Flavors & Fragrances' narrative projects US$8.4b revenue and US$840.4m earnings by 2029. This incorporates an 8.0% yearly revenue decline and an earnings change of about US$1.63b from a current loss of US$791.0m.
Uncover why International Flavors & Fragrances' fair value indicates a 13% potential upside to its current price and why this gap could narrow quickly.
Some of the most optimistic analysts see AQUASCENT slotting into a bigger story for International Flavors & Fragrances around higher quality earnings. Before this launch, the bullish camp was already modeling about US$8.1b in 2029 revenue and roughly US$1.1b in earnings. The takeaway is simple: opinions differ widely, so treat AQUASCENT as a fresh reason to recheck those assumptions rather than a detail that leaves old forecasts untouched.
Explore 2 other International Flavors & Fragrances fair value estimates, including one that suggests as much as 24% upside from the current price.
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
If AQUASCENT has you rethinking what you want from fragrance suppliers, it can help to widen the lens and compare International Flavors & Fragrances with other businesses that fit different risk and income profiles using the Simply Wall St Screener.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com